Hantavirus: A Comprehensive Contemporary Review of Virology, Global Epidemiology, Clinical Variants, Diagnosis, Treatment, and Intensive Care Management.
{"title":"Hantavirus: A Comprehensive Contemporary Review of Virology, Global Epidemiology, Clinical Variants, Diagnosis, Treatment, and Intensive Care Management.","authors":"As Anoop Kumar, Joshua John","doi":"10.5005/jp-journals-10071-25215","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hantaviruses are negative-sense, single-stranded RNA viruses of the family Hantaviridae that cause two potentially lethal zoonotic syndromes: Hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS). With approximately 2,00,000 reported cases of HFRS annually worldwide and case-fatality rates reaching 36-40% in severe HCPS, hantaviruses constitute a significant global public health burden. Rodent excreta are the principal source of human infection through inhalation of infectious aerosols.</p><p><strong>Materials and methods: </strong>A comprehensive literature search was conducted using PubMed, Embase, WHO databases, and CDC surveillance reports (1993-2025) to synthesize current evidence on hantavirus taxonomy, epidemiology, pathogenesis, clinical features, diagnosis, treatment, and intensive care unit (ICU) management.</p><p><strong>Findings: </strong>More than 50 distinct hantavirus species are now recognized, classified broadly into Old World (HFRS-causing) and New World (HCPS-causing) viruses. Sin Nombre virus (SNV) dominates in North America, while Andes virus (ANDV)-the only hantavirus documented to spread person-to-person-causes the majority of HCPS cases in South America. Hantaan virus (HTNV) remains the most common HFRS pathogen in Asia. Diagnosis relies on reverse transcriptase polymerase chain reaction (RT-PCR) during the 1st week of illness and immunoglobulin M (IgM)/immunoglobulin G (IgG) serology thereafter. Ribavirin reduces mortality in HFRS when given early; no antiviral is definitively proven for HCPS. Extracorporeal membrane oxygenation (ECMO) has transformed survival in severe HCPS. Favipiravir and monoclonal antibody therapies are under active investigation.</p><p><strong>Conclusion: </strong>Hantavirus infections demand a high index of clinical suspicion, especially in occupationally exposed or rural populations. Timely diagnosis, evidence-based ICU protocols, and stringent rodent control are the cornerstones of management.</p><p><strong>How to cite this article: </strong>Kumar ASA, John J. Hantavirus: A Comprehensive Contemporary Review of Virology, Global Epidemiology, Clinical Variants, Diagnosis, Treatment, and Intensive Care Management. Indian J Crit Care Med 2026;30(5):430-442.</p>","PeriodicalId":47664,"journal":{"name":"Indian Journal of Critical Care Medicine","volume":"30 5","pages":"430-442"},"PeriodicalIF":2.0000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13337826/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Critical Care Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10071-25215","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/25 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Hantaviruses are negative-sense, single-stranded RNA viruses of the family Hantaviridae that cause two potentially lethal zoonotic syndromes: Hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS). With approximately 2,00,000 reported cases of HFRS annually worldwide and case-fatality rates reaching 36-40% in severe HCPS, hantaviruses constitute a significant global public health burden. Rodent excreta are the principal source of human infection through inhalation of infectious aerosols.
Materials and methods: A comprehensive literature search was conducted using PubMed, Embase, WHO databases, and CDC surveillance reports (1993-2025) to synthesize current evidence on hantavirus taxonomy, epidemiology, pathogenesis, clinical features, diagnosis, treatment, and intensive care unit (ICU) management.
Findings: More than 50 distinct hantavirus species are now recognized, classified broadly into Old World (HFRS-causing) and New World (HCPS-causing) viruses. Sin Nombre virus (SNV) dominates in North America, while Andes virus (ANDV)-the only hantavirus documented to spread person-to-person-causes the majority of HCPS cases in South America. Hantaan virus (HTNV) remains the most common HFRS pathogen in Asia. Diagnosis relies on reverse transcriptase polymerase chain reaction (RT-PCR) during the 1st week of illness and immunoglobulin M (IgM)/immunoglobulin G (IgG) serology thereafter. Ribavirin reduces mortality in HFRS when given early; no antiviral is definitively proven for HCPS. Extracorporeal membrane oxygenation (ECMO) has transformed survival in severe HCPS. Favipiravir and monoclonal antibody therapies are under active investigation.
Conclusion: Hantavirus infections demand a high index of clinical suspicion, especially in occupationally exposed or rural populations. Timely diagnosis, evidence-based ICU protocols, and stringent rodent control are the cornerstones of management.
How to cite this article: Kumar ASA, John J. Hantavirus: A Comprehensive Contemporary Review of Virology, Global Epidemiology, Clinical Variants, Diagnosis, Treatment, and Intensive Care Management. Indian J Crit Care Med 2026;30(5):430-442.
期刊介绍:
Indian Journal of Critical Care Medicine (ISSN 0972-5229) is specialty periodical published under the auspices of Indian Society of Critical Care Medicine. Journal encourages research, education and dissemination of knowledge in the fields of critical and emergency medicine.